Suppr超能文献

口服植物组合物UP446的生殖和发育毒性 - 第二部分:对产前和产后发育的影响,包括对斯普拉格 - 道利大鼠母体功能的影响

Reproductive and Developmental Toxicity of Orally Administered Botanical Composition, UP446-Part II: Effects on Prenatal and Postnatal Development, Including Maternal Function in Sprague-Dawley Rats.

作者信息

Yimam Mesfin, Lee Young-Chul, Hyun Eu-Jin, Jia Qi

机构信息

Unigen, Inc, Seattle, Washington.

Unigen, Inc, Dongnam-Gu, Cheonan-Si, Chungnam, Korea.

出版信息

Birth Defects Res B Dev Reprod Toxicol. 2015 Aug;104(4):153-65. doi: 10.1002/bdrb.21142. Epub 2015 Jun 1.

Abstract

Almost all herbal remedies could be therapeutic at one dose and toxic at another. These facts become more troubling and a double threat when uncharacterized medicinal herbs are blended together and used by expectant mothers as a supplement to conventional pregnancy management with an inherent belief of considering herbal remedies as harmless. Here we describe the potential adverse effects of UP446, a standardized bioflavonoid composition from the roots of Scutellaria baicalensis and the heartwoods of Acacia catechu, on the maternal and their first filial generation (F1) developmental and functional toxicity following exposure at doses of 250, 500, and 1000 mg/kg/day. Maternal gestation, viability index, sex ratio, body weight, and food consumption were evaluated. F1 growth and development, sexual function including mating index, fertility, implantation, and embryo mortality were also assessed. Test substance impacts on the maternal (F0) or F1 reproductive parameters were very minimal. There were no statistically significant differences in implantation, parturition, viability, and neonates' sex ratios. There were no significant changes in maturation, behavioral, or functional developments between groups. No treatment-related prenatal or postnatal in-life or necropsy abnormalities were observed. Therefore, the no observed adverse effect level in the prenatal and postnatal developments, including maternal function study was considered to be greater than 1000 mg/kg.

摘要

几乎所有草药疗法在一种剂量下可能具有治疗作用,而在另一种剂量下则可能有毒性。当未明确特性的草药混合在一起,并被准妈妈们用作传统孕期管理的补充剂,且她们固有地认为草药疗法无害时,这些情况就变得更加令人担忧且构成双重威胁。在此,我们描述了UP446(一种来自黄芩根和儿茶心材的标准化生物类黄酮组合物)在以250、500和1000毫克/千克/天的剂量暴露后,对母体及其第一代子代(F1)发育和功能毒性的潜在不良影响。评估了母体的妊娠期、存活指数、性别比、体重和食物消耗量。还评估了F1的生长发育、性功能,包括交配指数、生育力、着床和胚胎死亡率。受试物质对母体(F0)或F1生殖参数的影响非常微小。着床、分娩、存活和新生儿性别比方面没有统计学上的显著差异。各组之间在成熟、行为或功能发育方面没有显著变化。未观察到与治疗相关的产前或产后生活期或尸检异常情况。因此,在包括母体功能研究在内的产前和产后发育中,未观察到不良影响水平被认为大于1000毫克/千克。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验